Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Milanez, J. R. C.
Right arrow Articles by Light, R. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Milanez, J. R. C.
Right arrow Articles by Light, R. W.
(Chest. 1994;106:1162-1165.)
© 1994 American College of Chest Physicians

Intrapleural Talc for the Prevention of Recurrent Pneumothorax

Jose Ribas C. Milanez M.D.1; Francisco S. Vargas M.D., F.C.C.P.1; Luiz Tarcisio B. Filomeno M.D.1; Angelo Fernandez M.D.1; Adib Jatene M.D.1; and Richard W. Light M.D., F.C.C.P.1

1 From the Hospital das Clinicas and the Instituto do Coracao of the Faculty of Medicine of the University of Sao Paulo, Brazil, and the Department of Medicine of the Veterans Administration Medical Center, Long Beach, Calif, and the University of California Irvine

The ipsilateral recurrence rate after the first spontaneous us pneumothorax treated with tube thoracostomy is reported to be between 23 percent and 52 percent. The incidence of recurrence after the first recurrence is substantially higher. Chemical pleurodesis has been attempted empted to decrease the recurrence rate. Tetracycline has been widely utilized, but parenteral tetracycline is no longer available. Therefore, alternative sclerosing agents have been used. Talc has been demonstrated to be effective in preventing recurrences and it has minimal long-term effects. This prospective study was designed to determine the efficacy of talc pleurodesis in patients with recurrent spontaneous pneumothorax. Eighteen patients admitted between May 1985 and March 1993 to the Department of Thoracic Surgery underwent thoracoscopy and were treated by tube thoracostomy with chemical pleurodesis. All the patients had had at least two pneumothoraces and six had had at least six pneumothoraces. Sterile asbestos-free talc, 2g, was aerosolized throughout the pleural surface. One or two chest tubes were inserted, left clamped for 2 h, and unclamped after this time. The tubes were removed when no air had escaped for 24 h. Only one (5.6 percent) patient had recurrence of the pneumothorax, and a second insufflation of talc resulted in no new recurrence after a follow-up of 10 months. The remaining 94.4 percent did not have recurrence of pneumothorax within an observation period of 38.5 ± 28.1 months. The follow-up was more than 2 years for 66.7 percent with no recurrence and was more than 5 years for 33.3 percent. We conclude from these observations that the insufflation of 2 g of talc into the pleural space is a safe effective treatment for control of recurrent spontaneous pneumothorax.

Submitted on November 12, 1993
Accepted on February 18, 1994




This article has been cited by other articles:


Home page
Eur Respir JHome page
R. V. Reddy, H. Mahdi, N. Watson, and M. B. A. Allen
A 29-year-old male with malaise, chest pain and night sweats
Eur. Respir. J., May 1, 2005; 25(5): 938 - 941.
[Full Text] [PDF]


Home page
Eur Respir JHome page
J-M. Tschopp, C. Boutin, P. Astoul, J-P. Janssen, S. Grandin, C-T. Bolliger, L. Delaunois, P. Driesen, G. Tassi, A-P. Perruchoud, et al.
Talcage by medical thoracoscopy for primary spontaneous pneumothorax is more cost-effective than drainage: a randomised study
Eur. Respir. J., October 1, 2002; 20(4): 1003 - 1009.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
J. R. M. de Campos, F. S. Vargas, E. d. C. Werebe, P. Cardoso, L. R. Teixeira, F. B. Jatene, and R. W. Light
Thoracoscopy Talc Poudrage : A 15-Year Experience
Chest, March 1, 2001; 119(3): 801 - 806.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
D. Gupta, A. Hansell, T. Nichols, T. Duong, J. G Ayres, and D. Strachan
Epidemiology of pneumothorax in England
Thorax, August 1, 2000; 55(8): 666 - 671.
[Abstract] [Full Text]


Home page
ChestHome page
J. R. M. de Campos, L. O. A. Filho, E. d. C. Werebe, H. Sette Jr., A. Fernandez, L. T. B. Filomeno, and F. B. Jatene
Thoracoscopy and Talc Poudrage in the Management of Hepatic Hydrothorax
Chest, July 1, 2000; 118(1): 13 - 17.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
M. Glazer, N. Berkman, J. S. Lafair, and M. R. Kramer
Successful Talc Slurry Pleurodesis in Patients With Nonmalignant Pleural Effusion
Chest, May 1, 2000; 117(5): 1404 - 1409.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
S. A. Sahn and J. E. Heffner
Spontaneous Pneumothorax
N. Engl. J. Med., March 23, 2000; 342(12): 868 - 874.
[Full Text] [PDF]


Home page
ChestHome page
T. Kinoshita, S. Miyoshi, M. Katoh, T. Yoshimasu, M. Juri, S. Maebeya, and Y. Naito
Intrapleural Administration of a Large Amount of Diluted Fibrin Glue for Intractable Pneumothorax
Chest, March 1, 2000; 117(3): 790 - 795.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
E. C. Werebe, R. Pazetti, J. R. Milanez de Campos, P. P. Fernandez, V. L. Capelozzi, F. B. Jatene, and F. S. Vargas
Systemic Distribution of Talc After Intrapleural Administration in Rats
Chest, January 1, 1999; 115(1): 190 - 193.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 by the American College of Chest Physicians.